Price loading...

The 2023-2028 Outlook for Targeted Therapy Liver Cancer Drugs in the United States

Price data last checked 94 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

No Price Data Available

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
26 October 2022
Listed Since
11 November 2022

Similar Products You Might Like

The 2023-2028 Outlook for Targeted Therapy Liver Cancer Drugs in India
98% match

The 2023-2028 Outlook for Targeted Therapy Liver Cancer Drugs in India

£515.00 24 Jan 2026
The 2023-2028 Outlook for Cancer Supportive Care Drugs in the United States
97% match

The 2023-2028 Outlook for Cancer Supportive Care Drugs in the United States

£520.00 22 Jan 2026
The 2023-2028 Outlook for Bile Duct Cancer (Cholangiocarcinoma) Treatments in the United States
97% match

The 2023-2028 Outlook for Bile Duct Cancer (Cholangiocarcinoma) Treatments in the United States

£520.00 10 Jan 2026
The 2025-2030 World Outlook for Targeted Therapy Liver Cancer Drugs
97% match

The 2025-2030 World Outlook for Targeted Therapy Liver Cancer Drugs

£790.00 11 Jan 2026
The 2023-2028 Outlook for Anti-Rejection Drugs and Immunosuppressants for Liver Diseases Treatments in the United States
97% match

The 2023-2028 Outlook for Anti-Rejection Drugs and Immunosuppressants for Liver Diseases Treatments in the United States

£520.00 23 Jan 2026
The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in the United States
97% match

The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in the United States

£520.00 21 Jan 2026
The 2023-2028 Outlook for Kidney Cancer Drugs in the United States
97% match

The 2023-2028 Outlook for Kidney Cancer Drugs in the United States

£520.00 13 Jan 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in the United States
97% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in the United States

£520.00 24 Jan 2026
The 2023-2028 Outlook for Cancer Supportive Care in the United States
97% match

The 2023-2028 Outlook for Cancer Supportive Care in the United States

£520.00 24 Jan 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in the United States
96% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in the United States

£520.00 26 Feb 2026
The 2023-2028 Outlook for Advanced Therapy Medicinal Products in the United States
96% match

The 2023-2028 Outlook for Advanced Therapy Medicinal Products in the United States

£520.00 14 Jan 2026
The 2023-2028 Outlook for Lymphoma Treatments in the United States
96% match

The 2023-2028 Outlook for Lymphoma Treatments in the United States

£520.00 29 Jan 2026
The 2016-2021 Outlook for Liver Cancer Drugs in the United States
96% match

The 2016-2021 Outlook for Liver Cancer Drugs in the United States

£595.00 11 Jan 2026
The 2023-2028 Outlook for Liver Health Supplements in the United States
96% match

The 2023-2028 Outlook for Liver Health Supplements in the United States

£520.00 06 Feb 2026
The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in the United States
96% match

The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in the United States

£520.00 14 Jan 2026
The 2023-2028 Outlook for Neuroendocrine Tumor Treatments in the United States
96% match

The 2023-2028 Outlook for Neuroendocrine Tumor Treatments in the United States

£520.00 05 Feb 2026
The 2023-2028 Outlook for Therapeutic Drug Monitoring in the United States
96% match

The 2023-2028 Outlook for Therapeutic Drug Monitoring in the United States

£520.00 22 Jan 2026
The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in the United States
96% match

The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in the United States

£520.00 12 Jan 2026
The 2023-2028 Outlook for Chemotherapy and Antibody Combination Antibody Therapies in the United States
96% match

The 2023-2028 Outlook for Chemotherapy and Antibody Combination Antibody Therapies in the United States

£520.00 11 Jan 2026
The 2023-2028 Outlook for Basal Cell Carcinoma Treatments in the United States
96% match

The 2023-2028 Outlook for Basal Cell Carcinoma Treatments in the United States

£520.00 12 Jan 2026
The 2023-2028 Outlook for Cancer Screenings in the United States
96% match

The 2023-2028 Outlook for Cancer Screenings in the United States

£520.00 15 Jan 2026
The 2023-2028 Outlook for Antiviral Drugs in the United States
96% match

The 2023-2028 Outlook for Antiviral Drugs in the United States

£520.00 30 Jan 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma in the United States
96% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma in the United States

£520.00 12 Jan 2026
The 2023-2028 Outlook for Cervical Cancer Treatments in the United States
96% match

The 2023-2028 Outlook for Cervical Cancer Treatments in the United States

£520.00 26 Jan 2026